The Minister of Health will monitor the drill in the national capital. (Figurative)
New Delhi:
A trial will take place in every state today to verify the best way to vaccinate people against COVID-19 and to fill the gaps in logistics and training. This unit will also test the operational feasibility of using the CoWIN application in a field environment. CoWIN, short for Covid Vaccine Intelligence Network, is a digital platform to implement and expand the vaccination campaign. The massive exercise comes a day after a government-appointed panel of experts recommended approval of the Oxford COVID-19 vaccine, made by the Serum Institute of India, to the regulator Drugs Control Authority of India. Today’s exercise is the second rehearsal to be carried out in the country; the first was on December 28 and 29 in Assam, Andhra Pradesh, Punjab and Gujarat.
Here are the top 10 points of this great story:
-
Some 96,000 vaccinators have been trained for this, the Health Ministry said. Of these, 2,360 participants have been trained in the National Training of Trainers and more than 57,000 have been trained at the district level in 719 districts.
-
The process, in which 25 health workers will receive mock vaccines at each location, is intended to test the mechanisms and reveal potential gaps in the system before the actual vaccination campaign. “An important focus of the trial will be the management of any possible adverse events after vaccination,” the Ministry of Health said in a statement.
-
Health Minister Harsh Vardhan called on officials in all states to ensure that vaccination sites and those responsible follow the checklist and standard operating procedure prepared by the Ministry of Health and shared with all states. and Union territories to guide them through the trial.
-
“Let’s try to implement it as a real exercise with attention to minute details. Proper coordination will go a long way towards generating mutual understanding so that the next vaccination campaign can continue without any problems,” said Health Minister, PTI news agency . reported.
-
The Minister of Health will monitor the drill in the national capital. The sites are the Guru Teg Bahadur Hospital in Shahdara, the urban primary health center in Daryaganj, and the Venkateshwar Hospital in Dwarka.
-
In Lucknow, the test will take place in six locations. In Pune, it will take place in three health centers, in addition to Nagpur, Jalna and Nandurbar. Chhattisgarh will conduct the drill in seven districts. The day trip will take place in four districts of Gujarat. Punjab will conduct the drill in Patiala, and Haryana will conduct the drill in Panchkula. In Kerala, the test will be held in four districts: Thiruvananthapuram, Idukki, Wayanad and Palakkad.
-
India is awaiting vaccination against COVID-19 and will start anytime soon after the regulator DCGI approves a vaccine. The Serum Institute of India (SII) is manufacturing the Covishield vaccine developed by the University of Oxford and leading drugmaker AstraZeneca, while Bharat Biotech has partnered with the Indian Council for Medical Research (ICMR) for its Covaxin.
-
On how much the vaccine would cost and who will pay for it, AIIMS director Dr. Randeep Guleria told NDTV: “Currently, the cost of the vaccine is funded by the government, so this will be something that will be done as part of a government initiative like any other – another vaccine program, I don’t think it’s going to cost anything. “
-
Cheaper and easier to distribute than rival vaccines, the AstraZeneca-Oxford vaccine could be a game changer for global immunization. Countries with a relatively basic health infrastructure have high hopes of an injection that, unlike Pfizer’s, can be stored and transported in normal refrigeration, rather than supercooled to -70 degrees Celsius.
-
Britain this week became the first country to authorize the AstraZeneca vaccine, ahead of other Western countries in their bid to halt a record rise in infections caused by a highly contagious form of the virus that has also appeared in India.
.
